Catherine Sebban

Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

Pierre Feugier, Ambro van Hoof, Catherine Sebban et al. · Journal of Clinical Oncology · 2005 · 1.5K citations

Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas

Isabelle Ray‐Coquard, Claire Cropet, M. van Glabbeke et al. · Cancer Research · 2009 · 780 citations · Full text

Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study

Corinne Haïoun, Éric Lepage, Christian Gisselbrecht et al. · Journal of Clinical Oncology · 2000 · 422 citations

Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients.

Y Bastion, Catherine Sebban, F Berger et al. · Journal of Clinical Oncology · 1997 · 307 citations

Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma

Philippe Moreau, Hervé Avet‐Loiseau, Thierry Façon et al. · Blood · 2011 · 302 citations